About SYNthesis Med Chem
SYNthesis Med Chem is a company based in Parkville (United States) founded in 2007 was acquired by Viva Biotech in September 2020.. The company has 1 employees as of June 30, 2019. SYNthesis Med Chem operates in a competitive market with competitors including Insitro, HotSpot Therapeutics, Certara, Inpharmatica and TOLREMO therapeutics, among others.
- Headquarter Parkville, United States
- Employees 1 as on 30 Jun, 2019
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Synthesis Med Chem (Uk) Limited
-
Annual Revenue
$545.16 K (USD)-4as on Jun 30, 2022
-
Net Profit
$-214.78 K (USD)-449as on Jun 30, 2022
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
1
as on Jun 30, 2019
-
Acquired by
Viva Biotech
(Sep 20, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of SYNthesis Med Chem
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in SYNthesis Med Chem
SYNthesis Med Chem has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Viva Biotech. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Drug discovery and development research services are provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by SYNthesis Med Chem
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - SYNthesis Med Chem
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Synthesis Med Chem Comparisons
Competitors of SYNthesis Med Chem
SYNthesis Med Chem operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, HotSpot Therapeutics, Certara, Inpharmatica and TOLREMO therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| domain | founded_year | HQ Location |
Developer of a platform for protein function analysis
|
|
| domain | founded_year | HQ Location |
Provider of a platform for in silico drug discovery and consulting services
|
|
| domain | founded_year | HQ Location |
Developer of predictive informatics based platform for drug discovery
|
|
| domain | founded_year | HQ Location |
Anti-cancer small molecules are developed to target drug resistance pathways.
|
|
| domain | founded_year | HQ Location |
Immune system-based drugs are discovered via biological data analytics.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Synthesis Med Chem
Frequently Asked Questions about SYNthesis Med Chem
When was SYNthesis Med Chem founded?
SYNthesis Med Chem was founded in 2007.
Where is SYNthesis Med Chem located?
SYNthesis Med Chem is headquartered in Parkville, United States.
How many employees does SYNthesis Med Chem have?
As of Jun 30, 2019, the latest employee count at SYNthesis Med Chem is 1.
What is the annual revenue of SYNthesis Med Chem?
Annual revenue of SYNthesis Med Chem is $545.16K as on Jun 30, 2022.
What does SYNthesis Med Chem do?
SYNthesis Med Chem was founded in 2007 and is based in Parkville, United States. Operations focus on the biotechnology sector, where small molecule drug discovery services are offered, including single compound synthesis. A library known as SYNkinase is maintained, containing kinase inhibitors and small molecule inhibitors for therapeutic proteins used in research. Molecular modeling solutions are also provided to support homology models of protein interactions in drug discovery processes.
Who are the top competitors of SYNthesis Med Chem?
SYNthesis Med Chem's top competitors include Insitro, HotSpot Therapeutics and Certara.
Who are SYNthesis Med Chem's investors?
SYNthesis Med Chem has 1 investor. Key investors include Viva Biotech.